Contrasting Definitive Healthcare (NASDAQ:DH) and Amesite (NASDAQ:AMST)

Definitive Healthcare (NASDAQ:DH) and Amesite (NASDAQ:AMST) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Definitive Healthcare and Amesite”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52 million	0.39	-$138.93 million	($1.62)	-0.55
Amesite	$110,000.00	34.52	-$3.62 million	($0.64)	-1.30

Amesite has lower revenue, but higher earnings than Definitive Healthcare. Amesite is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and target prices for Definitive Healthcare and Amesite, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3	3	1	1	2.00
Amesite	1	0	0	0	1.00

Definitive Healthcare presently has a consensus target price of $2.77, indicating a potential upside of 212.16%. Given Definitive Healthcare’s stronger consensus rating and higher probable upside, research analysts clearly believe Definitive Healthcare is more favorable than Amesite.

Insider and Institutional Ownership

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 3.6% of Amesite shares are held by institutional investors. 16.3% of Definitive Healthcare shares are held by company insiders. Comparatively, 36.0% of Amesite shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Definitive Healthcare and Amesite’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
Amesite	-1,024.91%	-118.33%	-103.03%

Volatility and Risk

Definitive Healthcare has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, Amesite has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500.

Summary

Definitive Healthcare beats Amesite on 11 of the 15 factors compared between the two stocks.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

About Amesite

Amesite Inc., an artificial intelligence driven platform and course designer, that provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. It serves businesses, universities and colleges, K-12 schools, museums, and non-profit organizations. Amesite Inc. was incorporated in 2017 and is headquartered in Detroit, Michigan.